T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

  • Justin F. Gainor
  • , Manish R. Patel
  • , Jeffrey S. Weber
  • , Martin Gutierrez
  • , Julie E. Bauman
  • , Jeffrey M. Clarke
  • , Ricklie Julian
  • , Aaron J. Scott
  • , Jessica L. Geiger
  • , Kedar Kirtane
  • , Celine Robert-Tissot
  • , Brandon Coder
  • , Moomal Tasneem
  • , Jing Sun
  • , Wei Zheng
  • , Lauren Gerbereux
  • , Andressa Laino
  • , Filippos Porichis
  • , Jack Russella Pollard
  • , Peijie Hou
    • Vasudha Sehgal, Xing Chen, Manju Morrissey, Hikmat N. Daghestani, Igor Feldman, Lakshmi Srinivasan, Joshua P. Frederick, Michelle Brown, Praveen Aanur, Robert Meehan, Howard A. Burris

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study'. Together they form a unique fingerprint.

Immunology and Microbiology

Keyphrases